MRSA 检测市场规模、份额及成长分析（按产品类型、检测类型、最终用户和地区）—产业预测，2025 年至 2032 年

2023 年全球 MRSA 检测市场规模价值为 45 亿美元，预计将从 2024 年的 46.8 亿美元成长到 2032 年的 64.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.1%。

全球 MRSA 检测市场正在经历显着成长，这得益于医疗保健系统对抗生素抗药性感染疾病的快速检测的迫切需求。抗药性金黄色葡萄球菌(MRSA) 仍然是一个主要的公共卫生问题，尤其是在医院环境中。随着 MRSA 感染的盛行率上升，对准确及时的诊断测试的需求也在增加。各种医疗机构对感染控制的重视程度不断提高，以及旨在遏制疫情爆发的照护现场和分子诊断技术的应用日益广泛，是市场扩张的主要驱动力。自动化平台和基于 PCR 的检测方法的进步提高了检测能力，改善了临床结果。此外，强制性筛检指南和人们对抗菌素抗药性日益增长的认识，正在鼓励诊断公司提供具有成本效益的解决方案，进一步将 MRSA 检测纳入全球感染控制策略。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术分析

MRSA 检测市场规模（依产品类型划分）及复合年增长率（2025-2032）

• 市场概览
• 装置
• 试剂和套件

MRSA 检测市场规模（依检测类型划分）及复合年增长率（2025-2032）

• 市场概览
• 免疫诊断测试
• 分子诊断检测

MRSA 检测市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 医院
• 诊断实验室
• 学术研究所

MRSA 检测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• 3M Co.
• Abbott Laboratories
• ALIFAX Srl
• Arlington Scientific Inc.
• Becton Dickinson and Co.
• bioMerieux SA
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Creative Diagnostics
• Danaher Corp.
• DiaSorin Spa
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• GENSPEED Biotech GmbH
• OpGen Inc.
• Puritan Medical Products Co.
• R Biopharm AG
• Sekisui Diagnostics LLC
• Uniogen Oy
• ZeptoMetrix LLC

结论和建议

Global MRSA Testing Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.68 billion in 2024 to USD 6.46 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The global MRSA testing market is witnessing significant growth, driven by healthcare systems' urgent need for rapid detection of antibiotic-resistant infections. Methicillin-resistant Staphylococcus aureus (MRSA) remains a major public health concern, particularly in hospital settings. As the prevalence of MRSA infections rises, so does the demand for accurate and timely diagnostic tests. The focus on infection control in various healthcare facilities is a key factor fueling market expansion, along with the increasing adoption of point-of-care and molecular diagnostic technologies aimed at curbing outbreaks. Advancements in automated platforms and PCR-based assays are enhancing detection capabilities, thus improving clinical outcomes. Additionally, mandatory screening guidelines and heightened awareness of antimicrobial resistance are pushing diagnostic companies to offer cost-effective solutions, further embedding MRSA testing into global infection control strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRSA Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRSA Testing Market Segments Analysis

Global MRSA Testing Market is segmented by Product Type, Test Type, End user and region. Based on Product Type, the market is segmented into Instruments and Reagents & Kits. Based on Test Type, the market is segmented into Immunodiagnostic Test and Molecular Diagnostic Test. Based on End user, the market is segmented into Hospitals, Diagnostic Laboratories and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MRSA Testing Market

The increasing prevalence of antibiotic-resistant bacteria, particularly MRSA and VRSA, is driving a surge in hospital-acquired infections, notably in high-risk environments like intensive care units and dialysis facilities. Contributing factors include prolonged hospitalizations and the use of invasive medical procedures. This alarming trend underscores the urgent necessity for enhanced infection control strategies, as evidenced by concerning rates of MRSA colonization documented by health organizations such as the CDC and NHS. Consequently, the global MRSA testing market is expanding to address these critical healthcare challenges and improve patient outcomes through more effective diagnostic and treatment options.

Restraints in the Global MRSA Testing Market

The Global MRSA Testing market faces challenges primarily related to patient safety, particularly for vulnerable populations that rely heavily on healthcare services. The transmission of MRSA primarily occurs through direct contact and the use of medical devices. Additionally, contamination issues extend beyond traditional healthcare settings, impacting industries such as telecommunications and electronics, especially during the surface mount technology (SMT) and printed circuit board (PCB) assembly processes. This highlights a pressing need for effective infection prevention measures across various sectors, emphasizing that MRSA concerns are not limited to healthcare environments alone. Addressing these challenges is crucial for overall safety and risk management.

Market Trends of the Global MRSA Testing Market

The Global MRSA Testing market is experiencing a significant trend towards the adoption of AI-powered diagnostic platforms, transforming traditional testing methodologies. These innovative tools enhance diagnostic workflows by automating result interpretation, expediting image analysis, and improving detection accuracy, ultimately fostering better patient outcomes. With the implementation of AI, laboratories can achieve quicker turnaround times and heightened operational efficiency, which is crucial in high-risk healthcare environments. This technological advancement not only streamlines the testing process but also empowers healthcare professionals to implement timely infection control interventions, reflecting a paradigm shift in MRSA management and detection strategies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global MRSA Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits

Global MRSA Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Immunodiagnostic Test
• Molecular Diagnostic Test

Global MRSA Testing Market Size by End user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes

Global MRSA Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Test Type, End user)
  • US
  • Canada
• Europe (Product Type, Test Type, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 3M Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALIFAX Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arlington Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSPEED Biotech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puritan Medical Products Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R Biopharm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uniogen Oy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations